| Nov 19 |
Neumora Therapeutics, Inc. (NMRA): This Small-Cap Stock Is Ready To Explode
|
| Nov 12 |
Neumora Therapeutics, Inc. (NMRA) Q3 2024 Earnings Call Transcript
|
| Nov 12 |
Neumora Therapeutics GAAP EPS of -$0.45 misses by $0.06
|
| Nov 12 |
Neumora Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
|
| Nov 12 |
Earnings Scheduled For November 12, 2024
|
| Nov 6 |
Neumora Therapeutics to Participate in Upcoming Conferences in November
|
| Oct 29 |
Neumora Therapeutics to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
|
| Oct 16 |
Neumora Therapeutics: A Story Of A Class II Biotech
|
| Oct 1 |
Neumora Therapeutics files for mixed securities shelf
|
| Oct 1 |
Neumora Therapeutics (NASDAQ:NMRA) Is In A Good Position To Deliver On Growth Plans
|
